Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (AMD3100)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified May 2011 by New York University School of Medicine
Sponsor:
Collaborators:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Stephen Warren, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01353937
First received: May 12, 2011
Last updated: April 25, 2013
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)